Skip to main content
. 2022 Jun 28;13:930041. doi: 10.3389/fphar.2022.930041

FIGURE 6.

FIGURE 6

Comprehensive analysis of LIPT1 in pan-cancers. (A) LIPT1 was differentially expressed in most cancer types. (C) Highly expressed LIPT1 showed good overall survival in multiple cancers. (B) The relationship between expression of LIPT1 and eight common immune checkpoints in pan-cancers. *p < 0.05, **p < 0.01, and ***p < 0.001.